Published in Cancer Weekly, November 15th, 1999
S.M. Corsello, of the Catholic University School of Medicine in Italy, and associates investigated the effect of tamoxifen on the growth hormone-IGF-1 axis. They presented their findings to attendees of the Sixth International Congress on Hormones and Cancer, held September 5-9, 1999 in Jerusalem, Israel. Their study was titled "Tamoxifen Inhibits IGF-1 Serum Levels without Affecting GH Response to GHRH in Women with Breast Cancer."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.